INDIRECT FLUORESCENT ANTIBODY MYCO— 510(k) K840012

Name: FDA 510(k) clearance K840012
Creator: U.S. Food and Drug Administration
Published: 1984-02-27

Substantially Equivalent

Zeus Technologies

FDA 510(k) clearance K840012 for INDIRECT FLUORESCENT ANTIBODY MYCO, Substantially Equivalent on 1984-02-27. Applicant: Zeus Technologies. Device class: 1.

Clearance details

Applicant: Zeus Technologies
Product code: Code GRZ
Device class: Class 1
Regulation: 21 CFR 866.3375
Advisory panel: Microbiology
Date received: 1984-01-04
Decision date: 1984-02-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GRZ

view all

K946373 — MYCOPLASMA SLURRY AND MYCOPLASMA CROWNTITRE IFA TEST SYSTEM1996-02-07
K944417 — ZEUA MYCOPLASMA1995-08-01
K931557 — FULLER LABORATORIES MYCOPLASM PNEUMONIA IFA-IGG TEST1994-03-11
K861716 — FIAX TEST KIT FOR MYCOPLASMA PNEUMONIAE-G ANTIBODY1986-08-08

More clearances from Zeus Technologies

view all

K831026 — INDIRECT FLUORESCENT ANTIBODY REAGENTS1983-06-22
K830783 — VERI-STAPH1983-04-08
K822859 — DIRECT FA CONJUGATE FOR LEGIONELLA SPP1983-02-16

Data sourced from openFDA. This site is unofficial and independent of the FDA.